Advertisement
News
Advertisement

GI Dynamics gets Australian OK for EndoBarrier

Mon, 07/25/2011 - 7:45am
Mass High Tech: The Journal of New England Technology

Lexington-based GI Dynamics Inc. recently received approval in Australia by the Therapeutic Goods Administration (TGA) to use its EndoBarrier Gastrointestinal Liner for the treatment of Type 2 Diabetes and obesity.

“Gaining approval to commercialize the EndoBarrier in Australia is another important milestone for our company,” said Stuart A. Randle, chief executive officer of GI Dynamics, in a statement.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading